Company: CCIXW
Filing Date: 2025-12-05
Form Type: S-4/A
Source: 0001193125-25-309933
Chunk: 57

Company: Churchill Capital Corp IX/Cayman
Filing Date: 2025-12-05
Form: S-4/A
Chunk 57
---
 to vote on the business combination?

Under CCIX’s current articles of association, CCIX must provide all holders of CCIX public shares with the opportunity to have their CCIX public shares redeemed upon the consummation of an initial business combination either in conjunction with a tender offer or in conjunction with a shareholder vote. For business and other reasons, CCIX has elected to provide its shareholders with the opportunity to have their CCIX public shares redeemed in connection with a shareholder vote rather than a tender offer. Therefore, CCIX is seeking to obtain the approval of its shareholders of the business combination proposal in order to allow CCIX public shareholders to exercise their redemption rights in connection with the Closing.

What will happen in the business combination?

Pursuant to the Merger Agreement and the related agreements, and upon the terms and subject to the conditions set forth therein, CCIX will acquire PlusAI and PlusAI will become a publicly traded company in a series of transactions we collectively refer to as the “ business combination ” or the “ Transactions .” The business combination is comprised of (1) the transfer of the registration of CCIX by way of continuation from the Cayman Islands to the State of Delaware (the “ Domestication ”), and (2) following the Domestication, the merger of Merger

<div align='center'>17</div>

Sub I with and into PlusAI, with PlusAI continuing as the surviving corporation, and immediately thereafter, such surviving corporation merging with and into Merger Sub II, with Merger Sub II continuing as the surviving entity and as a wholly-owned subsidiary of CCIX. Subject to the assumptions described herein, as of the date of this proxy statement/prospectus, we estimate that approximately shares of Post-Closing Company common stock will be issued to holders of PlusAI common stock in the Merger, in exchange for all outstanding shares of PlusAI common stock (including shares of PlusAI common stock resulting from the conversion of PlusAI preferred stock and PlusAI SAFEs immediately prior to the Closing). It is also anticipated that we will reserve for issuance up to (1) shares of Post-Closing Company common stock in respect of the PlusAI options and unvested PlusAI RSUs assumed pursuant to the terms of the Merger Agreement and (2) shares of Post-Closing Company common stock in respect of the PlusAI warrants assumed pursuant to the terms of the Merger Agreement. The reserved shares referred to in clause (1) of the immediately preceding sentence are not included in the shares the sale and issuance of which